A growing body of evidence suggests that LSD, psilocybin, and other hallucinogenic drugs may have therapeutic benefits for patients with psychiatric disorders, according to a research review in the September issue of Journal of Psychiatric Practice. The journal is published in the Lippincott portfolio by Wolters Kluwer.
Pharmacogenetic tests are marketed as an aid to psychiatrists in selecting the antidepressant or antipsychotic medication that will work best in individual patients, based on their genetic makeup. But for most patients, these pharmacogenetic tests don't provide much useful information, beyond a basic understanding of how antidepressant and antipsychotic drugs are metabolized, suggests a study in the Journal of Psychiatric Practice. The journal is published in the Lippincott portfolio by Wolters Kluwer.
Parents of twins and other multiple-birth children experience higher than average rates of depression, anxiety and other mental health issues, particularly during the first three months, according to a survey study in the May issue of Journal of Psychiatric Practice. The journal is published by Wolters Kluwer.
Cognitive therapies should be considered when addressing the harmful psychological consequences of trauma in victims of human trafficking, according to a review and recommendations in the Journal of Psychiatric Practice. The journal is published by Wolters Kluwer.
Amid changing attitudes toward death and dying, some people with serious physical and/or mental illnesses are claiming a right to choose the time, place, and manner of their death. Discussions about "pre-planned death" pose new challenges for psychiatrists and other healthcare professionals to consider, according to an article in the September Journal of Psychiatric Practice, published by Wolters Kluwer.